Guo Haixia, Li Na, Sun Yaping, Wu Cuiling, Deng Huixia, Xu Ling, Yang Xu
Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Institute of Systems Biology, Shenzhen Bay Laboratory, Shenzhen, China.
Front Oncol. 2021 Sep 8;11:734588. doi: 10.3389/fonc.2021.734588. eCollection 2021.
Although had been validated to participate in multiple cancers including leukemia, the role of polymorphisms in acute lymphoblastic leukemia (ALL) was still not clear. In this study, we aimed to evaluate the association between single nucleotide polymorphisms (SNPs) and ALL risk in children.
A total of 687 pediatric ALL cases and 971 cancer-free controls from two hospitals in South China were recruited. A case-control study by genotyping three SNPs in the gene (rs285162 C>T, rs285207 A>C, and rs2070235 A>G) was conducted. The associations were assessed by odds ratios (ORs) with corresponding 95% confidence intervals (CIs). Subgroup and stratification analyses were conducted to explore the association of rs285207 with ALL risk in terms of age, sex, immunophenotype, risk level, and other clinical characteristics. The false-positive report probability (FPRP) analysis was performed to verify each significant finding. Functional analysis in silico was used to evaluate the probability that rs285207 might influence the regulation of .
Our study demonstrated that rs285207 was related to a decreased ALL risk (adjusted OR = 0.78; 95% CI = 0.63-0.97, = 0.022) in the dominant model. The associations of rs285207 with ALL risk appeared stronger in patients with pre B ALL (adjusted OR=0.56; 95% CI=0.38-0.84, =0.004), with normal diploid (adjusted OR=0.73; 95% CI=0.57-0.95, =0.017), with low risk (adjusted OR=0.68; 95% CI=0.49-0.94, =0.021), with lower WBC (adjusted OR=0.62; 95% CI=0.43-0.87, =0.007) or lower platelet level (adjusted OR=0.76; 95% CI=0.59-0.96, =0.023). With FPRP analysis, the significant association between the rs285207 polymorphism and decreased ALL risk was still noteworthy (FPRP=0.128). Functional analysis showed that IKZF1 bound to DNA motif overlapping rs285207 and had a higher preference for the risk allele A. As for rs285162 C>T and rs2070235 A>G, no significant was found between them and ALL risk.
In this study, we revealed that rs285207 polymorphism decreased the ALL risk in children, and rs285207 might alter the binding to IKZF1, which indicated that the gene polymorphism might be a potential biomarker of childhood ALL.
尽管[基因名称]已被证实参与包括白血病在内的多种癌症,但该基因多态性在急性淋巴细胞白血病(ALL)中的作用仍不清楚。在本研究中,我们旨在评估[基因名称]单核苷酸多态性(SNP)与儿童ALL风险之间的关联。
招募了来自中国南方两家医院的687例儿童ALL病例和971例无癌对照。通过对[基因名称]基因中的三个SNP(rs285162 C>T、rs285207 A>C和rs2070235 A>G)进行基因分型开展病例对照研究。通过比值比(OR)及相应的95%置信区间(CI)评估关联。进行亚组和分层分析以探讨rs285207与ALL风险在年龄、性别、免疫表型、风险水平和其他临床特征方面的关联。进行假阳性报告概率(FPRP)分析以验证每个显著发现。利用计算机模拟功能分析评估rs285207可能影响[基因名称]调控的概率。
我们的研究表明,在显性模型中,rs285207与ALL风险降低相关(调整后的OR = 0.78;95% CI = 0.63 - 0.97,P = 0.022)。rs285207与ALL风险的关联在早前B-ALL患者中似乎更强(调整后的OR = 0.56;95% CI = 0.38 - 0.84,P = 0.004),在正常二倍体患者中(调整后的OR = 0.73;95% CI = 0.57 - 0.95,P = 0.017),在低风险患者中(调整后的OR = 0.68;95% CI = 0.49 - 0.94,P = 0.021),在白细胞计数较低的患者中(调整后的OR = 0.62;95% CI = 0.43 - 0.87,P = 0.007)或血小板水平较低的患者中(调整后的OR = 0.76;95% CI = 0.59 - 0.96,P = 0.023)。通过FPRP分析,rs285207多态性与ALL风险降低之间的显著关联仍然值得注意(FPRP = 0.128)。功能分析表明,IKZF1与重叠rs285207的DNA基序结合,并且对风险等位基因A有更高的偏好。至于rs285162 C>T和rs2070235 A>G,未发现它们与ALL风险之间存在显著关联。
在本研究中,我们揭示了rs285207多态性降低了儿童ALL风险,并且rs285207可能改变与IKZF1的结合,这表明[基因名称]基因多态性可能是儿童ALL的潜在生物标志物。